RMEAX Mutual Fund (Aspiriant Risk-Managed Equity Allocation Fund Adv Shs) is managed by Aspiriant Funds with $1.43B in net assets. RMEAX expense ratio is 0.98%, holding 131 positions across sectors including Unknown, Other, Information Technology. Inception date: 2013-04-04.

RMEAX performance shows a YTD return of 6.76%. The 1-year return is 16.21% and the 5-year return is 8.27%. RMEAX dividend yield stands at 11.05%, paid annually.

RMEAX top holdings include Gmo Quality Fund Class Vi (35.5%), Rief Strategic Partners Fund (7.5%), Schwab Fundamental Emerging Markets Large Company Index ETF (7.1%), Baillie Gifford Funds - The Emerging Markets Fund (4.8%), Gmo Equity Dislocation Investment Fund (4.3%). View all RMEAX holdings, sector breakdown, or dividend history.

RMEAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RMEAX alternatives are available via the screener, along with tax-loss harvesting opportunities.